In animal studies, the LPS+MDZ group showed a decreasing trend associated with the rate of bone resorption.
← all excerpts
Potential for Drug Repositioning of Midazolam as an Inhibitor of Inflammatory Bone Resorption.
1
—
—
In animal studies, the LPS+MDZ group showed a decreasing trend associated with the rate of bone resorption.